Drug recall
Rifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only, Manufactured for: Mylan Institutional…
FDA recall event 89910 · Class II · Mylan Pharmaceuticals Inc
Key facts
| Event ID | 89910 |
|---|---|
| Recall numbers | D-0774-2022 |
| Recalling firm | Mylan Pharmaceuticals Inc |
| Product type | Drugs |
| Products | Rifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505 U.S.A., NDC 67457-445-60 |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Failed Impurities/Degradation Specifications: High out of specification results obtained for related compound during stability testing. |
| Initiation date | Apr 7, 2022 |
| Report date | Apr 27, 2022 |
| Termination date | May 23, 2023 |
| City | Morgantown |
| State | WV |
| Country | United States |
| FEI number | 1110315 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: